Grants for For profit organizations other than small businesses - Science and Technology

The intent of the FY24 Transforming Care Award (TrCA) is to support research that provides answers and solutions in critical areas to improve quality of life, reduce caregiver burden and stress, reduce health disparities, and increase support for the individual with a diagnosis of Alzheimers disease and related dementias (AD/ADRD), their care partner/caregiver, and/or both, as well as the impact on families and/or communities. For this mechanism, family is broadly defined as the family of choice and/or the family of origin. Additionally, the TrCA definition of care does not include medical care (such as medical interventions administered by a physician), as the care landscape extends beyond that of medical interventions to be inclusive of research into integration, education, and support. The PRARP requires projects to ensure strategies maintain the dignity of the individual living with a dementia diagnosis and their family/care/social communities. All applications submitted to this funding opportunity must clearly indicate how the project addresses a critical unmet need, explain how the research will be representative of the population it intends to benefit, and demonstrate cultural competence. Culturally competent research factors the cultural background and diversity of the intended beneficiaries of the research outcomes when developing research ideas, conducting research, and implementing the research findings. Cultural competency in research is critical in reducing health disparities and enhancing the quality and impact of research by ensuring inclusivity, understanding, and responsiveness to the needs of diverse populations. The TrCA targets research that includes, but is not limited to, improvements in long-term care, quality of life, psychosocial wellness, and supporting aging-in-place, belonging, and community living for individuals, care partners, and families living with a dementia diagnosis. Studies may include, but are not limited to, topics such as considerations for dementia care that are specific to military Service Members and/or Veterans and their Families, navigating the AD/ADRD diagnosis and care path, and overcoming care partner/caregiver stress. Projects may address knowledge gaps, interventions, strategies, technologies, and/or tools. Clinical research and clinical trials are allowed, however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity. Key elements of this award mechanism are: Person-centered research: All applications to the FY24 PRARP TrCA should be person- centered. This mechanism is intended to provide answers and solutions in critical areas to improve quality of life, reduce burden and stress, and increase support for individuals living with a diagnosis, their families, and their care partners (hereafter referred to as Community(ies) in this Funding Opportunity). The research should have near-immediate impact on the intended beneficiaries. To facilitate success, the TrCA requires Community collaboration for all projects. Focus on outcomes: The intent of the TrCA is to advance knowledge and capacity in the AD/ADRD care field. As such, applicants should clearly articulate outcomes, clearly demonstrate a pathway of feasibility, and identify realistic approaches to scaling and Community level implementation for widespread use. Additionally, applications should plan for and describe how the research will be manualized (i.e., compiled in a manual) and fed back into the research, lived experience, and care communities. See Attachment 6, Research Manual and Progression Plan. Representation: Awards supported by the PRARP are expected to address gaps in representative AD/ADRD data sets. Applicants must prioritize diversity and equity in clinical study populations including, but not limited to, social and structural determinants of health such as sex, gender, ethnicity, culture, socioeconomic status, geography, and health care access, are expected. Projects supported by this mechanism must represent a non-incremental advance in the care field. Preliminary data are required. For this mechanism, studies utilizing animal models do not meet the intent of the mechanism and are not allowed. Milestone meeting: The Principal Investigator (PI) will be required to present an update on progress toward accomplishing the goals of the award at a Milestone Meeting to be held in the National Capital Area during years 2-4 of the period of performance. The PI may bring up to three additional members of the research team, including their Community partner, to the meeting. The Milestone Meeting will be attended by members of the PRARP Programmatic Panel, CDMRP staff, the USAMRAA Grants/Contracts Officer, and other stakeholders. Optimizing research impact through Community collaboration: Research funded by the FY24 PRARP should be responsive to the needs of Communities in the remainder of the Funding Opportunity, maximizes the translational and impact potential of the proposed research. Establishing and utilizing effective and equitable collaborations and partnerships with members of the AD/ADRD lived experience Communities is essential to maximize the translational and impact potential of the proposed research. Collaborative research approaches feature shared responsibility and ownership for the research project to ensure fully integrated involvement of Community members within the research team. Collaborative research approaches such as Community-based participatory research, participatory action research, and integrated knowledge transition, generate partnerships between scientific researchers and Community members to create knowledge useable by both sets of stakeholders. Recognizing the strengths of each partner, scientific researchers and Community members must collaborate and contribute their expertise equitably on all aspects of the project, which may include needs assessment, planning, research intervention design, implementation, evaluation, and dissemination. Research results are jointly interpreted, disseminated, fed back to affected communities, and may be translated into interventions or policy. These methods are critically important for Community-level interventions and can also augment the potential impact of a research program on people living with dementia, their families, and/or their care partners. These collaborative relationships are often established through integrating Community members into research teams as co-researchers, advisors, and consultants. Some examples for Community collaborations include: Lived Experience Consultation: The research team includes at least one project advisor with AD/ADRD lived experience who will integrate with the research team to provide consultation throughout the planning, implementation, and dissemination of the research project. Lived experience consultants (LECs) may include individuals with an AD/ADRD diagnosis, their family members, care partners, or others as appropriate. Partnership with a Community-Based Organization: The research team establishes partnerships with at least one Community-based organization that provides consultation throughout the planning, implementation, and dissemination of the research project. Community-based organizations may include advocacy groups, service providers, policymakers, or other formal organizational stakeholders. Community Advisory Board (CAB): A CAB is composed of multiple Community stakeholders and can take many forms, from a board of LECs to a coalition of Community-based organizations, or any combination thereof. As with LECs and organizational partners, the CAB provides consultation throughout the planning, implementation, and dissemination of the research project. Career Initiation or Transition (CIT) Partnership Option: The FY24 PRARP encourages applications that include meaningful and productive collaborations between two principal investigators. To promote enhanced research capacity within the AD/ADRD field, the FY24 TrCA includes an option for a CIT Principal Investigator (PI) to partner with an experienced investigator to jointly address a research question. The CIT PI must have nominal, if any, research support in the field and may be either one of the following: The Career Initiation PI must be an early-career researcher, at least 3 years post their terminal degree but no more than 7 years into their independent position. Both PIs may have similar or disparate expertise, but each PI is expected to bring distinct and complimentary contributions to the application. The Career Transition PI must be an investigator (at any stage) who is new to the military health, TBI, or AD/ADRD field(s). New to the field is defined as having only nominal, if any, publications in the field. The other partnering investigator must have complimentary experience (as evidenced by publications) in military health, TBI, and/or AD/ADRD field(s). The CIT is structured to accommodate two PIs. One PI will be identified as the Initiating PI and will be responsible for most of the administrative tasks associated with application submission. The other will be identified as a Partnering PI. Either PI can be the CIT PI. Both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. Both PIs may have experience in similar or disparate scientific disciplines, but each PI is expected to bring distinct and complimentary contributions to the application. If recommended for funding, each PI will be named to an individual award within the recipient organization(s). For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.

This grant provides funding for researchers and organizations to conduct observations and studies related to the solar system, supporting a wide range of scientific investigations in space and planetary sciences.

The "DoD Multiple Sclerosis, Clinical Trial Award" is a grant that funds the implementation of clinical trials aimed at significantly impacting the treatment or management of multiple sclerosis, ranging from small proof-of-concept trials to large-scale trials, with the expectation that the proposed trial will begin within 12 to 18 months after the award date.

The FY24 Transformative Breast Cancer Consortium Award is designed to support collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applicants must bring together different perspectives to develop new paradigms that will solve fundamental yet overarching problems in breast cancer. This award requires a team-based approach by a consortium of exceptional researchers and advocates, whose collaborative efforts will make a transformative impact in breast cancer. The transformation intended by the consortium must be in peoples lives, and not in the healthcare or research system.This funding opportunity is a separate mechanism from the Transformative Breast Cancer Consortium Development Award, which is intended to provide successful applicants the time and resources needed to bring investigators and breast cancer advocates together to establish a consortium framework and conduct preliminary research to support application to a future, full Transformative Breast Cancer Consortium Award (pending availability of funds). For FY24, investigators may be named as Consortium Director on an application submitted to either (but not both) of these mechanisms. It is not necessary to receive a development award in order to apply for the current funding opportunity or anticipated full consortium awards in the future. Detailed information on the FY24 Transformative Breast Cancer Consortium Development Award is available under a separate program announcement (HT942524BCRPTBCCDA).For the FY24 Transformative Breast Cancer Consortium Award, the consortium should have at least four, but no more than five, project teams, each investigating different projects under a central hypothesis. No more than two project teams may be based at one institution. Each teams work must be integrated within the consortium so that every component is working toward the consortiums central hypothesis. Note: This award is not intended to replace, supplement, duplicate, or compete with other collaborative research efforts, such as the National Cancer Institute (NCI) Specialized Programs of Research Excellence (SPOREs), and it should not represent a collection of related Program Project grants or subprojects.The proposed consortiums overall work is expected to be innovative. In addition, the Transformative Breast Cancer Consortium Award will include funds for seed projects to pursue brand-new, high-risk/high-reward concepts that arise from the work, during the award period.DOD FY24 Transformative Breast Cancer Consortium Award 5The Breast Cancer Landscape describes the reality of breast cancer and identifies overarching challenges to progress the field. Research funded under this award mechanism should result in answers that will fundamentally and significantly transform and disrupt the present landscape.Applications submitted to the Transformative Breast Cancer Consortium Award must include the following: Research that includes truly innovative and brand-new, paradigm-shifting work in breast cancer that will address vital issues in a unique way. The issues may be one (or more) of the FY24 BCRP Overarching Challenges or, with justification, may be a different issue that meets the intent of the award mechanism and addresses the mission of ending breast cancer. If the application identifies a different fundamental issue, it must be coupled with at least one of the FY24 BCRP Overarching Challenges. Research that includes different disciplines that come together to address ending breast cancer with an ecologic approach. The consortiums proposed research must look at all aspects of the disease and bring together these different perspectives into one overarching plan for a deep, definitive dive into the FY24 BCRP Overarching Challenge(s) or other fundamental issue identified in the application. The plan also should include issues related to the hypothesis that have not been previously addressed or answered. A plan that describes in detail the integration across the consortium in all aspects, including administration, logistics, and substance. Applications must describe the substantive integration across and among teams that are necessary for the work. The required communication plan and administrative management plan will not suffice to show integration, nor will identifying individual team members who will cross teams. A detailed explanation of the substantive research processes that will be integrated is required.Synergistic, highly integrated, multidisciplinary, and multi-institutional research teams of leading scientists, clinicians, and consumer advocates must be assembled into a consortium to address a major problem in a way that could not be accomplished by a single investigator or group. While the project teams are made up of different groups, each with its own Principal Investigator (PI), the teams must be working on the major problem identified in the Transformative Breast Cancer Consortium Award application and under the leadership of the Consortium Director. The research proposed in Transformative Breast Cancer Consortium Award applications may include phase 1 clinical trials and collaborations with pharmaceutical or biotechnology industry scientists and/or companies, as appropriate. However, a clinical trial is not required, and the primary thrust of the application should not be a clinical trial.Although not all-inclusive, applications that propose the following as the primary effort(s) or central hypothesis of the consortium will not meet the intent of this award mechanism: NCI Program Project or SPORE grants or applications Conducting drug screens or testing a cocktail of therapeutics Targeting a single gene or protein Developing a new derivative or formulation of an old drug Conducting genomic landscape mapping analyses Seeking to improve existing technologies (e.g., mammography or magnetic resonance imaging screening)All applications submitted to the Transformative Breast Cancer Consortium Award must address the following key features:1. IMPACTDemonstrate potential to transform or improve the lives of individuals with, and/or at risk for, breast cancer. The time to the final impact may vary, but the outcomes of the effort must be transformative and significantly advance the BCRPs mission of ending breast cancer. A clear and compelling presentation of how the effort will be transformative for individuals with, and/or at risk for, breast cancer must be provided. Applications proposing research that represents an incremental advance in breast cancer do not meet the intent of this award mechanism.2. INNOVATIONPursue innovative, high-risk/high-reward research that has the potential to change existing paradigms, or develop new paradigms. Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities. In addition to the requirement that the consortiums overall research be innovative, applications must describe a plan to support the pursuit of innovative concepts through seed projects, i.e., the development of new concepts that emerge during the course of the award. These seed projects should enable the research team to explore new avenues of high-risk/high-reward ideas that were not part of the original application, but that develop during the project and are within the scope of the overall vision of the research. A portion of the total direct budget costs (no more than 5%) must be reserved to support the seed projects, and these funds may not be used for equipment or travel.3. CONSORTIUMIntegrate project teams consisting of preeminent investigators and advocates from appropriate disciplines and institutions. Applications should include a robust consortium of researchers with the combined backgrounds and breast cancer-related expertise to enable successful conduct of the proposed research. Emphasis must be placed on integrating the most highly qualified investigators and advocates to focus on the research problem, regardless of their location. These investigators must include highly accomplished scientists, clinicians, and promising young investigators in the targeted areas of research who collectively represent the best team to solve the problem(s) identified. The proposed research effort should be broad enough to require a multidisciplinary approach that is reflected in the composition of the consortium team. Inclusion of scientists from nontraditional disciplines is encouraged.The award mechanism is structured with a Consortium Director and at least three, but no more than four, Project Team PIs representing at least two institutions. The Consortium Director is responsible for the day-to-day management of the consortium, as well as for leading their own project team. The Consortium Director, together with the Project Team PIs, are jointly responsible for leading and executing the proposed research projects that are integrated into a central hypothesis and will result in answers that will fundamentally and significantly transform and disrupt the present breast cancer landscape. Please see the top of this section, Section II.B, Award Information, for more details.Incorporate breast cancer consumer advocates into every aspect of the proposed consortiums activities. Applications are required to include consumer advocate involvement. The consortium team must include at least one breast cancer consumer advocate per project team. The consumer advocates are expected to represent the perspective of the patient population(s) that are most relevant to the consortiums proposed research. Breast cancer consumer advocates must have an active role in every aspect of the proposed consortiums work including consortium conception and design, ongoing discussion, decisions and oversight, program evaluation, and dissemination of information to the public. Consumer advocates must be integrated into and play an active role in the leadership and decision-making committees for the consortium at each participating institution. Examples of appropriate integration include membership on the advisory board(s) and steering committee(s), participation in each project team, and attendance at all consortium-related meetings. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer, they should be part of a breast cancer advocacy organization, and their role in the project should be independent of their employment. They cannot be employees of any of the institutions participating in the application. They must have a high level of familiarity and training involving science and current issues in breast cancer research.4. INTEGRATIONProvide a plan that describes in detail the integration across the consortium in all aspects, including administration, logistics, and substance. Applications must demonstrate the substantive integration across and among teams that are necessary for the work. The integration plan must provide a detailed explanation of the substantive research processes that will be integrated.5. IMPLEMENTATIONProvide a strategy for implementation. Projects must demonstrate solid scientific rationale, and applications must include published and/or preliminary data that support the feasibility of their hypotheses and/or approaches. The application must include a detailed research management plan that identifies critical milestones, outlines the innovations and technical solutions that will be implemented to accomplish the milestones, and explains how these solutions will ultimately be translated to individuals with, and/or at risk for, breast cancer. It is expected that the proposed plan will present an exceptional level of innovation and creativity.Accelerate research progress through communication. Communication between and among consortium team members is essential to the success of the consortium. Applications must include a strategy for sharing data in real time and using information technologies to facilitate timely and effective communication and cooperation. The communication plan should specify the processes and tools to be used for regular and structured communication. The consortium should take full advantage of state-of-the-art communication and data sharing tools in addition to formal and informal meetings. The framework for the communication plan must be part of the application and the individual(s) who will maintain the data sharing and communications technologies must be identified.Provide an effective, coordinated administrative management plan that integrates and optimizes the research and collaborations. The Consortium Director is required to commit a minimum level of time and effort of 25% to direct and manage an initiative of this magnitude, as well as lead their own project team. The Consortium Director must have the scientific ability and proven administrative ability to oversee large research programs and a proven record of leadership, including experience in the effective use of communication tools and the management of multifaceted and multidisciplinary projects. The administrative management plan must explain how the consortium will be organized and managed, and specify the processes and tools to be used for project meeting scheduling, reviews of research findings, ensuring multidisciplinary authorship of all publications arising from the consortiums work, and other issues of common concern to the consortium and its investigators. The administrative management plan also must describe procedures and processes that will be used to maximize the resources (e.g., databases, animal models) and products (e.g., antibodies) generated by the consortium and how these resources and products will be made available to the scientific community. A portion of the total direct budget costs must be reserved for a program manager.Award Structure: The Transformative Breast Cancer Consortium Award is structured to accommodate up to five PIs (the Consortium Director and three or four Project Team PIs). The Consortium Director will be responsible for the majority of the administrative tasks associated with application submission and the day-to-day management of the consortium. In addition, the Consortium Director will be responsible for leading their own project team. The Consortium Director and Project Team PIs each have different submission requirements; however, all PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. If recommended for funding, each PI will be named on separate awards to the recipient organizations. For individual submission requirements for the Consortium Director and Project Team PIs, refer to Section II.D.2, Content and Form of the Application Submission.The Consortium Director, Project Team PIs, and consumer advocates will be required to present an update on progress toward accomplishing research milestones and goals of the consortium and each project at an annual In-Progress Review (IPR) Meeting for the Transformative Breast Cancer Consortium Award. The intent of the IPR Meeting is to assess research progress, address problems, and define future directions. Annual IPR Meetings will be held at the conclusion of year 1 and every subsequent year in the period of performance and will be attended by members of the BCRP Programmatic Panel, CDMRP staff, and the USAMRAA Grants Officer to facilitate oversight and provide feedback to the consortium. IPR Meetings will either be held in person in the National Capital Region or virtually, at the discretion of the government. Continued funding may be contingent upon the successful completion of specific research milestones and goals. Research milestones from the approved SOW will be determined during the award negotiation process.In addition to IPR Meetings, each consortium must hold biannual workshops, which may be held at the PIs institutions or virtually, to facilitate ongoing communication and exchange of information within the consortium, as well as with advisory board(s) and/or steering committee(s).

The City of Chicago Department of Planning & Development (DPD) offers grant funding to support local commercial, mixed-use, and light manufacturing projects. This initiative aligns with the city's broader mission to strengthen local business corridors and enhance neighborhood vitality, particularly through the Chicago Recovery Plan. The program aims to invest in catalytic developments that build upon DPD's existing investments, supporting a resilient and thriving urban environment. The target beneficiaries for this grant program include community developers, business owners, entrepreneurs, and property owners within Chicago. While applicants from all areas of Chicago are eligible, priority is given to projects located in historically disinvested areas or those with limited private investment. The impact goals are to foster economic growth, enhance community safety initiatives, and leverage local talents, capacities, and institutions to contribute to neighborhood strength. The program prioritizes capital improvement projects, including pre-development, construction, or renovation costs. Mixed-use projects are eligible, though residential-only developments are not. A key focus is on catalytic projects that demonstrate a strong local impact and have clear momentum, with an expectation to break ground within six months of grant acceptance. Site control is preferred but not strictly required. Expected outcomes include the successful completion of vital community projects, increased economic activity in targeted areas, and the creation of more vibrant and resilient neighborhoods. Measurable results would involve the number of projects funded, the scale of investment leveraged, and the tangible improvements in business corridors and community infrastructure. The city's strategic priority is to address historical disinvestment and ensure equitable development across Chicago, utilizing funding sources such as the Chicago Recovery Plan Community Development (Large Grants), Neighborhood Opportunity Fund (Large Grants), and Tax Increment Financing to achieve these goals.

This funding opportunity supports U.S. institutions in establishing a national center to coordinate and enhance research on Alzheimer's Disease and related dementias through data collection, integration, and collaboration efforts.

This grant provides funding for innovative research and development of advanced quantum computing systems that integrate various architectural approaches to significantly improve performance, targeting a wide range of organizations including universities, businesses, and research centers.

This funding opportunity supports the establishment of a center to coordinate research on cellular senescence, aiming to improve health outcomes by identifying tissue-specific markers and developing new therapeutic strategies, targeting a wide range of eligible applicants including educational institutions, nonprofits, and businesses.

The DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award is a funding opportunity aimed at supporting the implementation of clinical trials that can significantly impact psychological health conditions and/or traumatic brain injury through the development of healthcare products, technologies, or practice guidelines.

This program provides financial support to organizations and event planners to develop and promote multi-day athletic events in Virginia Beach, boosting tourism and the local economy.

This funding opportunity provides financial support to businesses and nonprofit organizations in Hennepin County, Minnesota, to implement projects that prevent waste and promote the use of reusable materials.

The Northeast Dairy Business Innovation Center (NE-DBIC) is offering the New Dairy Processor Start-up Grant program to support new dairy processing projects across the Northeast. The core mission of this program is to foster competitive dairy processing businesses with long-term viability. This aligns with a broader strategic objective of strengthening the regional dairy industry by enabling operations of all sizes to successfully launch and sustain their products in the marketplace. By focusing on start-up operations and tangible implementation, the NE-DBIC aims to facilitate direct economic impact and product innovation within the dairy sector. The program targets several key beneficiaries, including dairy farmers ready to begin processing, value-added entrepreneurs with proven experience in dairy processing or business startups, and dairy processors established after January 1, 2023, who are in their start-up phase. The impact goals are centered on developing these businesses, supporting their entry into the market, and ultimately contributing to the economic vitality of the Northeast dairy industry. By providing financial assistance for start-up operations, the program seeks to create new opportunities for dairy-related businesses and products. The program's priorities and focuses are clearly on tangible implementation rather than earlier stages like research and development, concept development, or initial planning. This indicates a strategic emphasis on getting products to market and establishing sustainable business models. Eligibility criteria further refine this focus, requiring applicants to be headquartered or based in the Northeast, demonstrate proof of concept, have a robust business plan, obtain necessary licenses, and show commitment from buyers or distributors by the end of the grant period. Expected outcomes include the successful launch of new value-added dairy products, the establishment of competitive and viable dairy processing businesses, and increased market access for Northeast dairy products. Measurable results would likely include the number of new businesses launched, the volume of new products brought to market, and the economic growth generated within the participating dairy sectors. The NE-DBIC's strategic priorities, as evidenced by this grant, involve direct investment in the operational start-up phase, aiming for a theory of change where targeted financial support leads to the successful commercialization and long-term sustainability of dairy processing ventures in the region.

This program provides financial support to property owners and businesses in downtown Bishop to improve building aesthetics, restore historic features, and stimulate economic growth through private investments.

The Restaurants Care Resilience Fund, a program of the nonprofit California Restaurant Foundation, aims to support independent restaurants in California. This initiative is a clear alignment with the foundation's mission to strengthen the restaurant community by providing crucial financial aid. The fund, powered by generous gifts from PG&E, SoCalGas, and SDG&E, is set to award 278 independent restaurants with grants of $5,000 in 2024. The primary beneficiaries of this program are independently owned, for-profit restaurants or commercial caterers in California. Specifically, eligible entities must be owned by a CA resident, operate 1-5 units, earn no more than $3 million in annual gross revenue (combined for all units), and be a commercial customer of either PG&E, SoCalGas, or SDG&E, while currently being open and active for business. Franchises, home businesses, food trucks, and meal prep companies are not eligible, ensuring the grants directly support small, independent operators. The impact goal is to bolster the resilience and sustainability of these businesses, particularly in areas of operational improvement, employee welfare, and recovery from unforeseen hardships. The fund prioritizes several key areas for grant utilization. These include investments in energy-efficient kitchen equipment, which also qualify for rebates, thereby maximizing the grant's value. Technology upgrades are another focus, supporting the adoption of essential systems like POS, website, accounting, HR, inventory management, and loyalty programs. Employee training, covering areas like program design, ServSafe certifications, and participation in industry training councils, is also a priority, recognizing the importance of a skilled workforce. Additionally, the grants can be used for retention bonuses to reward employees and for addressing unforeseen hardships such as robbery, vandalism, fire, flood, or natural disasters experienced within the last 12 months. The expected outcomes are a more resilient and modern independent restaurant sector in California. Measurable results will include the number of restaurants receiving grants, the types of investments made (e.g., number of energy-efficient equipment purchases, technology upgrades implemented, employees trained, or retention bonuses distributed), and the number of businesses recovering from hardships. While not explicitly detailed as a strategic priority or theory of change within the provided text, the foundation's approach appears to be a direct intervention model, providing financial resources to address immediate needs and foster long-term stability and growth for small businesses within the restaurant industry. This strategy directly contributes to economic stability and community welfare by supporting a vital sector.

The Connecticut Department of Transportation (CT DOT) is offering the 2024 Active Transportation Microgrant Program to solicit projects aimed at improving active transportation. This grant program aligns with a mission to foster equitable, safe, accessible, and sustainable transportation options, thereby encouraging healthier and more environmentally friendly travel modes. The program's core objective is to make conditions safer for individuals of all ages to engage in walking, biking, and other active forms of transit, contributing to broader community well-being and environmental sustainability. The primary beneficiaries of this program include municipalities, schools, school districts, and nonprofit organizations, all of which are encouraged to apply. The impact goals are centered on enhancing access and conditions for active transportation users across Connecticut. This includes increasing safety for pedestrians and cyclists, promoting the use of non-motorized transport, and supporting educational initiatives that raise awareness about active transportation benefits and safety. The program prioritizes non-infrastructure projects, explicitly excluding design and construction costs. Eligible activities focus on improving access and conditions for active transportation users. This includes providing bicycle helmets, locks, lights, and maintenance training. It also covers the rental or purchase of bicycle fleets, including adaptive bicycles, League Cycling Instructor (LCI) training, and various programs and materials for pedestrian and bicycle safety education, such as safety vests. The emphasis is on practical, immediate interventions that directly support active transportation without requiring extensive infrastructural development. Expected outcomes and measurable results include an increase in the adoption of active transportation methods, a reduction in accidents involving pedestrians and cyclists due to enhanced safety measures, and a rise in community participation in active transportation events and educational programs. The funding limits for individual microgrants range up to $5,000, with an overall grant size between $1,000 and $10,000, indicating a focus on numerous smaller-scale, impactful projects rather than a few large ones. This approach suggests a strategic priority to broadly distribute resources to foster active transportation at a grassroots level across various communities in Connecticut.

The Clackamas County Public Health Division (CCPHD) Tobacco Prevention and Education Program (TPEP) is offering a grant opportunity to independently owned convenience stores in Clackamas County, Oregon. The program's core mission is to mitigate the adverse public health effects of tobacco by incentivizing retailers to cease tobacco sales and transition to a business model that actively supports community health. This initiative aligns with broader public health goals of reducing tobacco use and promoting healthier environments, reflecting a strategic priority to leverage economic incentives for positive health outcomes within the community. The primary beneficiaries of this grant are independently operated convenience stores located in Clackamas County that are not part of a corporate franchise. These stores must hold a valid Oregon Tobacco Retail License and actively sell tobacco products as of the application deadline. The impact goal is to transform these retailers into pillars of community health by fostering environments that offer healthier product choices and reduce access to tobacco. This change is expected to lead to improved public health indicators within Clackamas County, particularly concerning tobacco-related illnesses and youth access. The program prioritizes supporting the transitioning retailers through various mechanisms. In addition to grant funding of up to $20,000, TPEP offers ongoing technical assistance from LivelihoodNW for business plan development, assistance with becoming authorized to accept SNAP and WIC benefits, connections to local producers for new product categories, professionally designed promotional materials, and earned media/community outreach. These comprehensive support services are designed to ensure the long-term success and sustainability of the new, healthy business models. Expected outcomes include retailers experiencing increased profits from higher mark-up products, an expanded customer base, savings on tobacco licenses, and enhanced public perception. Measurable results will likely involve a reduction in tobacco sales outlets in Clackamas County, an increase in the availability of healthy food options in participating stores, and heightened community awareness of the benefits of healthy retail. The theory of change posits that by empowering individual retailers with financial incentives and robust support, a ripple effect will occur, positively influencing community health and inspiring other businesses to consider similar transitions.

The FY24 PRARP TrRA is intended to support studies that will make transformative and advanced contributions to reduce risk of or prevent the development of AD/ADRD. Risk reduction considering TBI and/or military service is of particular interest to the program. The work should significantly accelerate efforts in AD/ADRD research and demonstrate significant impact toward improving patient care and/or quality of life. To meet the intent of the funding opportunity, applications must robustly address an important problem or a critical barrier to progress in prevention and risk reduction. The proposed research may include, but is not limited to, exploring questions in the following areas: Identification of risk factors (environmental, genetic, epigenetic, lifestyle, etc.). Identification and implementation of strategies to reduce AD/ADRD risk and prevent cognitive problems following TBI and/or military service. Understanding the role of social determinants of health in risk reduction. Informational (not descriptive) epidemiology to understand environmental and other factors that contribute to development of AD/ADRD. All applications submitted to this funding opportunity must clearly indicate how the project addresses a critical unmet need, explain how the research will be representative of the population it intends to benefit, and demonstrate cultural competence. Culturally competent research factors the cultural background and diversity of the intended beneficiaries of the research outcomes when developing research ideas, conducting research, and implementing the research findings. Cultural competency in research is critical in reducing health disparities and enhancing the quality and impact of research by ensuring inclusivity, understanding, and responsiveness to the needs of diverse populations. Key elements of this award mechanism include: Research should be robust: The FY24 PRARP TrRA mechanism is geared toward supporting robust, well-designed research projects that provide significant impact on the AD/ADRD field, persons living with dementia, and their families, care-partners/caregivers. Inclusion of collaborative Community partner approaches is strongly encouraged for all projects and is required for all projects involving clinical research. Use of animal models must be fully justified for relevance to human health. Non-incremental advancement: Research projects should leverage existing knowledge to accelerate ideas, strengthen evidence, and move the field forward. Therefore, preliminary data are required. Projects proposing incremental advances that do not significantly propel the field do not meet the intent of this mechanism. Feedback to the Community: Applicants are expected to articulate a plan for relaying the results and outcomes of the research supported by this mechanism must be relayed back to the research/Community(ies) to allow for continued knowledge building. Optimizing research impact through Community collaboration: Research funded by the FY24 PRARP should be responsive to the needs of people living with AD/ADRD. Community collaboration is required for clinical research projects and encouraged for preclinical studies. Establishment and utilization of effective and equitable collaborations and partnerships with members of the AD/ADRD lived experience, family, and care partner communities, which will be referred to as Community(ies) in the remainder of the Funding Opportunity, maximizes the translational and impact potential of the proposed research. Collaborative research approaches feature shared responsibility and ownership for the research project to ensure non-tokenistic involvement of Community members within the research team. Collaborative research approaches such as Community-based participatory research, participatory action research, and integrated knowledge transition generate partnerships between scientific researchers and Community members to create knowledge useable by both sets of stakeholders. Recognizing the strengths of each partner, scientific researchers and Community members must collaborate and contribute their expertise equitably on all aspects of the project, which may include needs assessment, planning, research intervention design, implementation, evaluation, and dissemination. Research results are jointly interpreted, disseminated, fed back to affected communities, and may be translated into interventions or policy. These methods are critically important for Community-level interventions and can also augment the potential impact of a research program on people living with dementia, their families, and/or their care partners. These collaborative relationships are often established through integrating Community members into research teams as co-researchers, advisors, and consultants. Some examples for Community collaborations include: Lived Experience Consultation: The research team includes at least one project advisor with AD/ADRD experience who will integrate with the research team to provide consultation throughout the planning, implementation, and dissemination of the research project. Lived experience consultants (LECs) may include individuals with AD/ADRD, their family members, care partners, or others as appropriate. Partnership with a Community-Based Organization: The research team establishes partnerships with at least one Community-based organization that provides consultation throughout the planning, implementation, and dissemination of the research project. Community-based organizations may include advocacy groups, service providers, policymakers, or other formal organizational stakeholders. Community Advisory Board (CAB) Utilization: A CAB is composed of multiple Community stakeholders and can take many forms, from a board of LECs to a coalition of Community-based organizations or any combination thereof. As with LECs and organizational partners, the CAB provides consultation throughout the planning, implementation, and dissemination of the research project. Career Initiation or Transition (CIT) Partnership Option: The FY24 PRARP encourages applications that include meaningful and productive collaborations between two principal investigators. To promote enhanced research capacity within the AD/ADRD field, the FY24 TrRA includes an option for a CIT Principal Investigator (PI) to partner with an experienced to jointly address a research question. The CIT PI must have nominal, if any, research support in the field and may be either one of the following: The Career Initiation PI must be an early-career researcher, at least 3 years post their terminal degree but no more than 7 years into their independent position. Both PIs may have similar or disparate expertise, but each PI is expected to bring distinct and complimentary contributions to the application. The Career Transition PI must be an investigator (at any stage) who is new to the military health, TBI, or AD/ADRD field(s). New to the field is defined as having only nominal, if any, publications in the field. The other partnering investigator must have complimentary experience (as evidenced by publications) in military health, TBI, and/or AD/ADRD field(s). The CIT is structured to accommodate two PIs. One PI will be identified as the Initiating PI and will be responsible for most of the administrative tasks associated with application submission. The other will be identified as a Partnering PI. Either PI can be the CIT PI. Both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. Both PIs may have experience in similar or disparate scientific disciplines, but each PI is expected to bring distinct and complimentary contributions to the application. If recommended for funding, each PI will be named to an individual award within the recipient organization(s). For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.

The 2024 Texas Rural Woman Grant, offered by Texas Woman's University, aims to foster economic development in rural Texas by empowering woman-owned small businesses to undertake innovative projects. This grant aligns with the university's mission to support women entrepreneurs and stimulate economic growth in underserved areas of the state. The program seeks to address the unique challenges faced by rural businesses, contributing to the overall economic well-being of Texas communities. The primary beneficiaries of this grant are existing rural, woman-owned small businesses in Texas. These businesses must be at least 51% directly owned and controlled by one or more U.S. citizen women who also reside in Texas. The grant focuses on for-profit corporations, partnerships, LLPs, LLCs, or sole proprietorships located and operated within eligible rural Texas counties. The impact goal is to encourage and enable these businesses to undertake new and innovative projects, thereby creating greater economic development activity in rural Texas. The grant prioritizes projects that involve the purchase of machinery, equipment, or technology; farm implements or machinery; the addition or acquisition of new inventory or raw materials; the purchase and installation of fixtures or display units; property improvements that will result in increased sales and revenue; and marketing or advertising campaigns. Any other business-related activity deemed aligned with the program's purpose by the Center for Women Entrepreneurs (CWE) is also eligible. This focus ensures that funding directly supports tangible growth and operational enhancements for the recipient businesses. The expected outcomes and measurable results include the successful implementation of new projects by ten woman-owned businesses, each receiving a $5,000 grant. Recipients are required to complete a small business training course, engage in three hours of small business advising/mentoring, and submit an approved business plan with three years of financials. These requirements are designed to not only provide immediate financial support but also equip business owners with the knowledge and resources for sustainable long-term success and growth, leading to increased sales and revenue for their businesses.

The North Carolina Department of Commerce is offering Rural Downtown Economic Development (RDED) Grants, a program designed to support downtown revitalization and economic development initiatives. The core mission of this grant program is to assist local governments in growing and leveraging their downtown districts as assets for economic growth, development, and prosperity. While the context does not explicitly detail the "foundation's strategic priorities and theory of change" in a separate section, the program's overall purpose and eligible activities implicitly align with strategies focused on strengthening local economies through targeted investment in public infrastructure and community assets within downtown areas. The primary beneficiaries of the RDED Grants are units of local government, specifically municipal or county governments located in Tier 1 or Tier 2 counties, and rural census tracts in Tier 3 counties within North Carolina. The impact goals are centered on fostering economic growth, retaining businesses, attracting customers, and creating or retaining jobs within downtown districts. The program aims to transform these areas into vibrant economic engines for their communities, ultimately leading to broader economic development and increased prosperity for residents. The program prioritizes and focuses on projects that involve public improvements aimed at business retention and customer attraction within business districts. It also strongly supports publicly owned downtown economic development initiatives that utilize main streets and downtown districts as economic catalysts. Furthermore, the grants facilitate publicly owned building improvements for community-wide or mixed-use development, ensuring public control and benefit. Specific eligible activities include improvements to public infrastructure (like lots, alleys, streetscapes, waterfront developments, and parks), renovations or additions to public buildings (such as community centers, theaters, and libraries), and mixed-use downtown developments incorporating retail, restaurant, service, professional, nonprofit, governmental, institutional, or residential uses. Expected outcomes include a strengthened local economy, increased job opportunities, enhanced public spaces, and revitalized downtown districts that serve as community hubs. Measurable results are directly tied to the maximum grant amount, which is capped at $850,000 per grantee and may not exceed $12,500 per projected job created or retained. This direct link to job creation and retention provides a clear metric for assessing the program's success in achieving its economic development objectives. The discretion of the Rural Infrastructure Authority in funding availability suggests an ongoing commitment to strategic investments that align with the state's broader rural development goals.

This program provides funding for research institutions and organizations to develop advanced techniques for improving the performance and reliability of quantum computing systems, specifically targeting applications in national defense.